metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology P-29 INCIDENCE AND ASSOCIATED FACTORS OF HEPATOCELLULAR CARCINOMA IN PATIENTS WI...
Información de la revista
Vol. 29. Núm. S1.
Abstracts of the 2023 Annual Meeting of the ALEH
(febrero 2024)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 29. Núm. S1.
Abstracts of the 2023 Annual Meeting of the ALEH
(febrero 2024)
Acceso a texto completo
P-29 INCIDENCE AND ASSOCIATED FACTORS OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION IN A SINGLE CENTER IN PERU: A RETROSPECTIVE STUDY.
Visitas
242
Williams Celedonio Campos1, César Castro Villalobos2, Rosario Mayorga Márquez2, Jorge Garavito-Rentería2, Rommel Zambrano- Huailla2
1 Gastroenterology Service, Arzobispo Loayza National Hospital, Lima, Perú
2 Liver Unit, Gastroenterology Service, Arzobispo Loayza National Hospital, Lima, Perú
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Descargar PDF
Estadísticas
Tablas (1)
Table. Univariate analysis of hepatocellular carcinoma
Suplemento especial
Este artículo forma parte de:
Vol. 29. Núm S1

Abstracts of the 2023 Annual Meeting of the ALEH

Más datos
Introduction and Objectives

Chronic Hepatitis B infection represents an isolated risk for the development of hepatocellular carcinoma. This study aimed to investigate the incidence of hepatocellular carcinoma and associated factors in patients with chronic Hepatitis B infection with at least 5-year follow-up.

Materials and Methods

Retrospective study. Patients with chronic hepatitis B infection with or without cirrhosis, who were treated at the Liver Unit of the National Hospital Arzobispo Loayza and had at least 5-year follow-up, were enrolled. Predictive scores for hepatocellular carcinoma such as REACH-B, PAGE-B, mPAGE-B, aMAP, CU-HCC, GAG-HCC, and LSM-HCC were calculated at enrollment. The crude and cumulative incidence of hepatocellular carcinoma in the study population was determined.

Results

68 patients, 51.5% were males, and 25% had cirrhosis. The average age was 46.24 years. The incidence of hepatocellular carcinoma was 2.94% with a cumulative incidence of 0.51 person-year. In the univariate analysis, increased liver stiffness (kPa) (OR:1.1 (95% CI: 1.001 - 1.3), p<0.05) and lower albumin (g/dL) was associated with an increased risk of hepatocellular carcinoma.

Conclusions

The incidence of hepatocellular carcinoma was 2.9%. Increased liver stiffness and lower albumin, signs of cirrhosis, were predictive factors of hepatocellular carcinoma.

El Texto completo está disponible en PDF
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos